Cetera Advisor Networks LLC Senseonics Holdings, Inc. Transaction History

Cetera Advisor Networks LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.5 - $0.73 $750 - $1,095	1,501 Added 7.05%	22,801 $12,000
Q3 2023 Nov 14, 2023	SELL	$0.5 - $1.05 $3,850 - $8,085	-7,700 Reduced 26.55%	21,300 $12,000
Q2 2023 Aug 09, 2023	SELL	$0.55 - $0.89 $165 - $267	-300 Reduced 1.02%	29,000 $22,000
Q1 2023 May 15, 2023	SELL	$0.68 - $1.25 $476 - $875	-700 Reduced 2.33%	29,300 $20,000
Q4 2022 Feb 14, 2023	SELL	$0.96 - $1.34 $480 - $670	-500 Reduced 1.64%	30,000 $30,000
Q2 2022 Aug 11, 2022	BUY	$0.94 - $1.94 $470 - $970	500 Added 1.67%	30,500 $32,000
Q1 2022 May 12, 2022	BUY	$1.54 - $3.71 $16,478 - $39,697	10,700 Added 55.44%	30,000 $59,000
Q4 2021 Feb 14, 2022	BUY	$2.58 - $3.91 $1,290 - $1,955	500 Added 2.66%	19,300 $52,000
Q3 2021 Nov 16, 2021	BUY	$2.77 - $4.05 $52,076 - $76,140	18,800 New	18,800 $64,000
Q3 2020 Nov 13, 2020	SELL	$0.36 - $0.53 $360 - $530	-1,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.39 - $0.69 $390 - $690	1,000 New	1,000 $0

138

80.6M

418K

219K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $279M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.